Last reviewed · How we verify

NCT06076551

Sex Difference of Coronary Microvascular Dysfunction in Patients With Non-obstructive Coronary Artery Disease

Recruiting now Last updated 26 March 2025
What this trial tests

trial testing Adenosine stress echocardiography in Microvascular Angina in 300 participants. Currently enrolling.

Timeline
1 February 2018
Primary endpoint
31 December 2025
31 December 2025

Quick facts

Lead sponsorKorea University Anam Hospital
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment300
Start date1 February 2018
Primary completion31 December 2025
Estimated completion31 December 2025
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Korea University Anam Hospital

Who can join

Adults 20 to 80, any sex, with Microvascular Angina. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Sex difference of coronary microvascular dysfunction evaluated by coronary flow reserve will be assessed in patients with non-obstructive coronary artery disease

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Sex differences of sequential changes in coronary blood flow and microvascular function in patients with suspected angina.
    Kim SR, Kim MN, Cho DH, Kim HD, et al · · 2024 · cited 3× · PMID 38112743 · DOI 10.1007/s00392-023-02358-2

Verify or expand the search:

Other recruiting trials for Microvascular Angina

Currently open trials in the same condition.

Other Korea University Anam Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06076551.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing